The Ratio of von Willebrand Factor to ADAMTS13 May Improve Sarcopenia Identification in Patients with Liver Cirrhosis: A Retrospective Study

Aim: Sarcopenia is prevalent in patients with liver cirrhosis (LC) and associated with increased mortality and poor outcomes. However, readily available, noninvasive biomarkers for sarcopenia screening remain limited. This study evaluated the clinical utility of the von Willebrand factor (VWF)/a disintegrin and metalloprotease with thrombospondin type 1 motif, member 13 (ADAMTS13) ratio as a biomarker for sarcopenia in patients with LC. Methods: We retrospectively analyzed 321 patients with LC. Sarcopenia was diagnosed according to the Japan Society of Hepatology criteria using computed tomography-derived skeletal muscle index and handgrip strength. ADAMTS13 and VWF levels were measured by enzyme-linked immunosorbent assay. Multivariate analyses identified factors associated with sarcopenia and overall survival. Results: Sarcopenia was diagnosed in 71 patients (22.1%). Patients with sarcopenia were older and had lower body mass index and hemoglobin levels. The VWF/ADAMTS13 ratio was significantly higher in patients with sarcopenia and negatively correlated with skeletal muscle index and handgrip strength. Multivariable logistic regression identified the VWF/ADAMTS13 ratio as an independent factor associated with sarcopenia (odds ratio 2.75, 95% confidence interval [CI]: 1.29–5.87, p < 0.01). A combined model including age, body mass index, hemoglobin, and VWF/ADAMTS13 ratio achieved an optimism-corrected area under the curve of 0.790 (95% CI: 0.730–0.850). Cox proportional hazards analysis demonstrated that an elevated VWF/ADAMTS13 ratio independently predicted poor overall survival (hazard ratio 1.67, 95% CI: 1.07–2.61, p < 0.05). Conclusions: The VWF/ADAMTS13 ratio was significantly associated with sarcopenia and may serve as a useful biomarker for its screening and identification in patients with LC.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-13
DOI
https://doi.org/10.3390/jcm15228890
Primary Topic
Nutrition and Health in Aging
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Ratio of von Willebrand Factor to ADAMTS13 May Improve Sarcopenia Identification in Patients with Liver Cirrhosis: A Retrospective Study

Hiroki Kachi, Hitoshi Yoshiji, Koh Kitagawa, Tadashi Namisaki et al.
2 links
Journal of Clinical Medicine
Nutrition and Health in Aging
article

The Ratio of von Willebrand Factor to ADAMTS13 May Improve Sarcopenia Identification in Patients with Liver Cirrhosis: A Retrospective Study

Hiroki Kachi, Hitoshi Yoshiji, Koh Kitagawa, Tadashi Namisaki, Yui Osaki, Hiroaki Takaya, Akira Mitoro, Satoshi Iwai, Akihiko Shibamoto, Norihisa Nishimura, Yukihisa Fujinaga, Yuki Motokawa, Hitoshi Mori, Shinya Sato, Yuki Tsuji, Kiyoshi Asada, Tomihiro Iwata, Takashi Inoue
article en

Abstract

Aim: Sarcopenia is prevalent in patients with liver cirrhosis (LC) and associated with increased mortality and poor outcomes. However, readily available, noninvasive biomarkers for sarcopenia screening remain limited. This study evaluated the clinical utility of the von Willebrand factor (VWF)/a disintegrin and metalloprotease with thrombospondin type 1 motif, member 13 (ADAMTS13) ratio as a biomarker for sarcopenia in patients with LC. Methods: We retrospectively analyzed 321 patients with LC. Sarcopenia was diagnosed according to the Japan Society of Hepatology criteria using computed tomography-derived skeletal muscle index and handgrip strength. ADAMTS13 and VWF levels were measured by enzyme-linked immunosorbent assay. Multivariate analyses identified factors associated with sarcopenia and overall survival. Results: Sarcopenia was diagnosed in 71 patients (22.1%). Patients with sarcopenia were older and had lower body mass index and hemoglobin levels. The VWF/ADAMTS13 ratio was significantly higher in patients with sarcopenia and negatively correlated with skeletal muscle index and handgrip strength. Multivariable logistic regression identified the VWF/ADAMTS13 ratio as an independent factor associated with sarcopenia (odds ratio 2.75, 95% confidence interval [CI]: 1.29–5.87, p < 0.01). A combined model including age, body mass index, hemoglobin, and VWF/ADAMTS13 ratio achieved an optimism-corrected area under the curve of 0.790 (95% CI: 0.730–0.850). Cox proportional hazards analysis demonstrated that an elevated VWF/ADAMTS13 ratio independently predicted poor overall survival (hazard ratio 1.67, 95% CI: 1.07–2.61, p < 0.05). Conclusions: The VWF/ADAMTS13 ratio was significantly associated with sarcopenia and may serve as a useful biomarker for its screening and identification in patients with LC.

Journal of Clinical MedicineVol. 15(22)
Nara Medical University (JP)
Japan Agency for Medical Research and Development
Good health and well-being
Nutrition and Health in Aging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon